CAC Form 4: Director Marie J. McCarthy Granted 388 Shares Under Equity Plan

Rhea-AI Filing Summary

Camden National Corporation (ticker: CAC) filed a Form 4 indicating that director Marie J. McCarthy acquired 388 shares of common stock on 06/20/2025. The shares were issued at an implicit value of $38.57 each under the company’s 2022 Equity and Incentive Plan as compensation in lieu of cash director fees. Following this routine grant, McCarthy’s direct beneficial ownership rises to 15,037.874 shares.

No shares were sold and no derivative securities were involved. The filing, signed by attorney-in-fact Christopher G. Hutchinson on 06/23/2025, contains no additional financial metrics, earnings data, or strategic announcements, making it a standard insider ownership update rather than a materially significant event.

Insights

Securities Analyst

TL;DR: Routine 388-share director grant; negligible ownership change and neutral market impact.

The Form 4 records a small equity grant to Director Marie J. McCarthy, valued at roughly $15k. Such issuances in lieu of board fees are common and do not reflect open-market buying pressure or new strategic insight. Her post-transaction stake of ~15k shares represents only a fraction of the bank’s outstanding float, implying minimal signalling value. With no derivative activity, sales, or additional disclosures, the filing is best viewed as housekeeping—important for governance transparency but unlikely to influence Camden National’s valuation or liquidity.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

McCarthy Marie J

(Last) (First) (Middle)

2 ELM STREET

PO BOX 310

(Street)

CAMDEN ME 04843

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
CAMDEN NATIONAL CORP [ CAC ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
06/20/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	06/20/2025		A		388(1)	A	$38.57	15,037.874	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Shares acquired under Camden National Corporation's 2022 Equity and Incentive Plan and Amendment in lieu of director fees.

Remarks:

	Christopher G. Hutchinson, POA	06/23/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did Camden National (CAC) report in the latest Form 4?

Director Marie J. McCarthy acquired 388 shares of common stock on 06/20/2025 under the 2022 Equity and Incentive Plan.

How many Camden National shares does Marie J. McCarthy own after the transaction?

Her direct beneficial ownership increased to 15,037.874 shares.

What was the price assigned to the shares acquired by the director?

The filing lists an implicit price of $38.57 per share for the 388 shares.

Did the Form 4 disclose any sales or derivative transactions?

No. The filing shows only an A (acquired) code for common stock; no sales or derivative security activity was reported.

When was the Form 4 signed and submitted?

Attorney-in-fact Christopher G. Hutchinson signed the form on 06/23/2025.